ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,124Medicare Part D Prescriptions Filled, Including Refills

Rank: 133 out of 617

$720K Total Retail Price of All Prescriptions

Rank: 24 out of 617

370 Patients Receiving at Least One Drug in Part D
60%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 370 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

12% of this provider’s 370 patients filled at least one prescription for a schedule three drug, compared to an average of 11%.

Risky Drugs to Seniors

0% of this provider’s 5,405 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$79 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
SIMVASTATIN 345 235 1 2
OMEPRAZOLE 333 205 2 3
LEVOTHYROXINE SODIUM 320 237 3 1
LOSARTAN POTASSIUM 220 181 4 22
FUROSEMIDE 179 137 5 4
HYDROCODONE-ACETAMINOPHEN 167 93 S3 6 8
TRAMADOL HCL 162 55 7 15
CARVEDILOL 156 129 8 19
POTASSIUM CHLORIDE 153 121 9 10
WARFARIN SODIUM 143 132 10 7
LISINOPRIL 140 98 11 5
AMLODIPINE BESYLATE 139 125 12 6
CYMBALTA 130 59 13 49
ZOLPIDEM TARTRATE 130 75 13 23
METFORMIN HCL 127 60 15 9
CITALOPRAM HBR 125 106 16 18
LOSARTAN-HYDROCHLOROTHIAZIDE 117 103 17 46
ROPINIROLE HCL 114 52 18 66
GLIMEPIRIDE 108 74 19 33
HYDROCHLOROTHIAZIDE 96 71 20 13
DONEPEZIL HCL 94 80 21 30
TAMSULOSIN HCL 90 65 22 26
PROAIR HFA 89 18 23 75
ATORVASTATIN CALCIUM 86 71 24 14
PRAVASTATIN SODIUM 86 71 24 21
SPIRIVA 78 58 26 61
RANITIDINE HCL 78 14 26 40
METOPROLOL SUCCINATE 77 37 28 12
PREDNISONE 73 25 29 31
ABILIFY 72 0 30 131
GABAPENTIN 70 39 31 16
PAROXETINE HCL 69 53 32 62
FLUTICASONE PROPIONATE 68 35 33 36
POLYETHYLENE GLYCOL 3350 68 45 33 32
METFORMIN HCL ER 67 39 35 72
NOVOLOG FLEXPEN 67 37 35 203
FLUOXETINE HCL 63 30 37 73
DIOVAN 61 45 38 41
CRESTOR 61 34 38 28
FENTANYL 61 0 S2 38 45
CARBIDOPA-LEVODOPA 59 46 41 69
VERAPAMIL ER 58 50 42 90
ADVAIR DISKUS 56 41 43 38
NEXIUM 56 26 43 43
TRAZODONE HCL 56 30 43 51
LAMOTRIGINE 55 12 46 154
PANTOPRAZOLE SODIUM 54 44 47 37
IBUPROFEN 54 0 47 140
MORPHINE SULFATE ER 53 19 S2 49 128
CELEBREX 53 42 49 63
CYCLOBENZAPRINE HCL 53 0 R 49 74
SERTRALINE HCL 52 26 52 20
JANUVIA 50 16 53 107
ALENDRONATE SODIUM 50 44 53 25
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 20, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.